<DOC>
	<DOCNO>NCT02077543</DOCNO>
	<brief_summary>The purpose study determine innocuity operability innovative tumor molecular cellular print ProTool .</brief_summary>
	<brief_title>Multicenter Safety Trial Assessing Innovative Tumor Molecular Cellular Print Medical Device Glioma</brief_title>
	<detailed_description>Diagnostic cancerology keep base biopsy exeresis tissue anatomopathologic analysis . Micro-invasive biopsy approach reduce chirurgical aggressivity also tissue amount The innovative Medical Device ProTool offer micro-invasive biopsy approach parallel classical chirurgical proceeding . It allow complete heterogeneity tumoral analysis peri-tumoral tissue environment .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<criteria>equal 18 year old patient affiliate social security similarly regime informed consent form sign glial tumor suspicion Stereotaxic biopsy indication Karnofsky score &gt; 70 % Hematological assessment : neutrophil &gt; 1500/mm3 Platelet &gt; 150 000 blood Creatinin normal alkaline Phosphatases transaminases two time normal Bilirubin &lt; 1.5 time normal Pregnant woman lactate mother Ward court guardianship Adult unable express consent Person deprive freedom judicial administrative decision Person hospitalize without consent Person legal protection Person participate another clinical study Intratumoral hemorrhage MRI detect Treatment anticoagulant antisludge treatment Active Infections non control medical affection psychiatric intercurrent non treat Evolutive cerebral oedema without corticoid response Non control Epilepsy without antiepileptic response Susceptibility Medical Device material allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>